Market Place
Sourcing Support
All News #Library
Others
Smart Immune Treats Leukemia Patient At Final Phase 1/2 Dose
02 May 2024 //
GLOBENEWSWIRE
Smart Immune appoints key new members to its Board of Directors
16 Feb 2024 //
GLOBENEWSWIRE
Smart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer
04 Dec 2023 //
GLOBENEWSWIRE
Smart Immune targets $54M Series A to advance T cell progenitor therapy
15 Nov 2023 //
ENDPTS
Smart Immune to host R&D KOL webinar on thymus-empowered ProTcell platform
10 Nov 2023 //
GLOBENEWSWIRE
Smart Immune to Present Details of Pioneering Study at ASH Annual Meeting 2023
02 Nov 2023 //
GLOBENEWSWIRE
Smart Immune Showcases Data and Presentations at ESGCT
12 Oct 2023 //
GLOBENEWSWIRE
Smart Immune receives 2.5m grant and 15m equity investment commitment from EIC
30 Mar 2023 //
GLOBENEWSWIRE
Smart Immune is selected for first cohort of the French Tech Health20 program
27 Mar 2023 //
GLOBENEWSWIRE
Smart Immune appoints world-class Clinical Advisory Board
21 Nov 2022 //
GLOBENEWSWIRE
Smart Immune appoints world-leading experts to its Scientific Advisory Board
28 Jul 2022 //
GLOBENEWSWIRE
Smart Immune Announces Oral Presentation of Cell-Fate Plasticity Data
20 May 2022 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.